Nu Skin Enterprises (NYSE:NUS) Q4 2025 Earnings call February 12, 2026 05:00 PM ET Company ParticipantsB.G. Hunt - VP of Treasurer and Investor RelationsDave Storms - Director of Equity ResearchJames Thomas - CFORyan Napierski - President and CEOOperatorGood day, and thank you for standing by. Welcome to the Q4 2025 conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question, please press star one ...

Financial Data and Key Metrics Changes - For Q4 2025, the company reported revenue of $370 million, with an earnings per share (EPS) of $0.29, aligning with expectations [17][24] - For the full year 2025, adjusted EPS was $1.27, up from $0.84 in the previous year, representing a 51% growth [16][20] - Gross margin for Q4 was 70.7%, down from 71.4% in the prior year, while the core Nu Skin business gross margin improved to 77.6% [17][19] - The company generated $1.49 billion in revenue for the full year, with a foreign currency headwind of approximately $13.4 million [18][21] Business Line Data and Key Metrics Changes - The core Nu Skin business saw a gross margin of 77.4% for the full year, an 80 basis point improvement over the prior year [19] - Selling expenses for the core business were 40.3% for the year, with expectations to maintain around 40% moving forward [20] Market Data and Key Metrics Changes - The company initiated pre-market operations in India in November 2025, with a formal market opening anticipated in late 2026 [5][12] - Latin America continues to show strong performance, providing insights for expansion into new emerging markets [13][44] Company Strategy and Development Direction - The company aims to focus on the $6.8 trillion wellness market with the launch of the Prysm iO Intelligent Wellness Platform [6][15] - Strategic priorities include expanding into India and improving operational performance and efficiencies [12][15] - The company plans to place over 100,000 Prysm iO devices by the end of 2026, targeting 10 million healthy households by 2030 [11][12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in returning to growth by the end of 2026, despite inherent switching costs during the transition [5][15] - The company is cautious about revenue projections for India, focusing on establishing local infrastructure and logistics [35][36] - Management highlighted the importance of the Prysm iO launch in enhancing customer engagement and lifetime value [10][24] Other Important Information - The company ended the quarter with approximately $240 million in cash and reduced outstanding debt to $224 million, resulting in an expanded net cash position [21] - The company returned approximately $11.8 million in dividends and $20 million in share repurchases during the year [21] Q&A Session Summary Question: Insights on Prysm's revenue contribution - Management indicated that the placement of Prysm devices will lead to subscriptions, with an estimated market value of around $300 per device, potentially generating $30 million from device sales alone [32] Question: Thoughts on India market potential - Management sees long-term potential in India but is cautious about immediate revenue forecasts, focusing on local infrastructure and logistics [36][37] Question: Guidance considerations and leverage points - Management discussed modeling for 2026, emphasizing gross margin expansion and maintaining selling expenses around 40% [40][41] Question: Other portfolio performance insights - Management highlighted the restaging of the Tru Face skincare line and improvements in various markets, including China and Latin America [43][44]

Q4 2025 Financial Overview Important Information Regarding Forward-Looking Statements: This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not ...

FOR IMMEDIATE RELEASE Exhibit 99.1 Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance Company provides initial outlook for Q1 and fiscal year 2026, forecasting a return to revenue growth by year's end PROVO, Utah — Feb. 12, 2026 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced fourth quarter and full-year 2025 revenue and earnings within guidance with more than 50% growth in earnings for 2025. Executive Summary Q4 2025 vs. Prior-year Quarter | Revenue | $370.3 millio ...

Core Insights - Nu Skin Enterprises reported fourth quarter and full-year 2025 results within guidance, achieving over 50% growth in earnings for the year [1] - The company anticipates a return to revenue growth by the end of 2026, driven by the global launch of Prysm iO intelligent wellness devices [1] Financial Performance - Q4 2025 revenue was $370.3 million, a decrease of 16.9% year-over-year, or 10.4% excluding Mavely revenue [1] - Full-year 2025 revenue totaled $1.49 billion, down 14.3% from 2024, or 10.7% excluding Mavely revenue [1] - Earnings per share (EPS) for Q4 2025 was $0.29, compared to a loss of $(0.73) in Q4 2024, or $0.38 excluding restructuring and other charges [1] - Full-year EPS for 2025 was $3.18, compared to $(2.95) in 2024, or $1.27 excluding Mavely gain and other charges [1] Customer and Affiliate Metrics - The total number of customers decreased by 10% to 748,796 in Q4 2025 compared to the previous year [1] - Paid affiliates decreased by 11% to 129,311, while sales leaders fell by 19% to 30,045 [1] Segment Performance - Revenue by region for Q4 2025 showed declines across all major markets, with the Americas down 9.8%, Southeast Asia/Pacific down 22.7%, and Mainland China down 7.8% [3] - For the full year 2025, revenue in the Americas decreased by 12.3%, Southeast Asia/Pacific by 14.3%, and Mainland China by 16.9% [3] Outlook for 2026 - Q1 2026 revenue is projected to be between $320 million and $340 million, reflecting a decline of 12% to 7% [1] - Full-year 2026 revenue is expected to range from $1.35 billion to $1.50 billion, with an EPS forecast of $0.80 to $1.20 [1] Strategic Initiatives - The company is focusing on aligning sales leaders around the launch of Prysm iO, with over 20,000 devices already distributed [1] - Pre-market activities in India are underway, with a full market opening anticipated in the latter half of 2026 [1]

Core Viewpoint - Nu Skin Enterprises, Inc. (NUS) is expected to report declines in both revenue and earnings for the fourth quarter of 2025, with revenue estimates at $382.7 million, reflecting a 14.1% decrease year-over-year [1]. Revenue Expectations - The Zacks Consensus Estimate for quarterly revenues is set at $382.7 million, indicating a 14.1% decline from the previous year's quarter [1]. - Management has guided fourth-quarter revenues between $365 million and $400 million, suggesting a year-over-year decline of 10-18% [4]. - Excluding the contribution from the divested Mavely business, revenues are projected to fall by 12-3% [4]. Earnings Projections - The consensus estimate for quarterly earnings remains unchanged at 30 cents per share, which represents a 21.1% decline from the same quarter last year [2]. - Nu Skin anticipates fourth-quarter earnings per share to be between 25 and 35 cents, down from adjusted earnings of 38 cents reported in the previous year [6]. Market Conditions - The company is facing a challenging macroeconomic environment affecting discretionary spending in beauty and wellness [3]. - There has been a decline in customers, paid affiliates, and sales leaders, indicating ongoing pressures in several markets [3]. - Increased competition in the social commerce beauty space, particularly in North America, is also impacting performance [4]. Geographic Performance - Latin America has shown strong performance, with revenues increasing by 53% year-over-year in the third quarter [5]. - Sequential growth was reported in Europe & Africa, Southeast Asia Pacific, South Korea, and Hong Kong & Taiwan, with improving trends noted in Mainland China [5]. Strategic Initiatives - The limited sales leader preview of Prysm iO and the start of pre-market activities in India are expected to influence fourth-quarter performance positively [5]. - Despite the anticipated decline in sales, Nu Skin has achieved five consecutive quarters of adjusted gross margin expansion, supported by product mix improvements and cost discipline [6].

Core Insights - Nu Skin Enterprises Inc. has announced the relaunch of "The Aging Myth: Unlocking the Mysteries of Looking and Feeling Young," an updated edition of the bestselling book by Dr. Joseph Chang, which signifies a milestone in evidence-based beauty and wellness [1] Company Developments - The relaunch integrates decades of research that support Nu Skin's science-led innovations, including ageLOC® technology [1]

Core Viewpoint - Since late last year, direct selling company executives have begun to sell their properties, including high-value estates and luxury homes, indicating a trend of cashing out for potential reinvestment opportunities [1][11]. Group 1: Property Sales - The co-founder of Nu Skin, Sandie Tillotson, has listed her penthouse in Manhattan for $80 million (approximately 557 million RMB) [5]. - This penthouse, located in the Mandarin Oriental Residences, spans over 8,000 square feet (about 743 square meters) and has not been on the market for over 20 years [5][9]. - The property was originally purchased for under $30 million in 2005, marking a significant appreciation in value [5][8]. Group 2: Market Trends - Other direct selling executives have also sold properties, such as the co-founders of DoTerra, who sold their estate for $43 million (approximately 300 million RMB), more than doubling their investment [11]. - Another direct selling company chairman sold a luxury home in Miami for $71.9 million, reflecting a 60% increase in value since its purchase five years ago [11]. - This trend suggests that these entrepreneurs are not only adept in business operations but also possess sharp investment acumen, seeking higher returns in other sectors [11].

Core Viewpoint - The article emphasizes the importance of investing in safe-haven assets and undervalued dividend-paying consumer staples stocks during periods of market volatility and geopolitical tension [1][2]. Group 1: Investment Strategy - Safe-haven assets like gold, silver, and U.S. Treasuries are recommended for hedging risks, although their effectiveness may vary [1]. - Consumer staples and utilities are considered safe investments due to their inelastic demand and established history of returning capital to shareholders [2]. Group 2: Selected Companies - **United Breweries Co. (CCU)**: - Benzinga Edge Value Score of 98.14, with a current dividend yield of 2.8% and a dividend payout ratio (DPR) of 58.9% [4]. - The stock trades at 16 times earnings and 0.85 times sales, showing positive price action [4]. - CCU shares have increased over 11% recently, with bullish indicators such as a Golden Cross and favorable MACD signals [7]. - **NuSkin Enterprises Inc. (NUS)**: - Benzinga Edge Value Score of 86.96, with a market cap of $540 million and a dividend yield of 2.08% [8]. - The company reduced its dividend payout from $0.39 to $0.06, but the current payout allows for future increases [8]. - NUS shares have risen 15% at the start of the year, indicating bullish momentum [11]. - **Cresud SACIF y A (CRESY)**: - Benzinga Edge Value Score of 93.82, with a dividend yield of over 5% and a DPR of 23.4% [12]. - The company operates in agriculture and real estate, providing diversification during geopolitical tensions [12]. - CRESY shares have formed a Golden Cross, with the 50-day SMA acting as support [15]. - **Weis Markets Inc. (WMK)**: - Benzinga Edge Value Score of 89.87, with a market cap of $1.68 billion and a dividend yield of 2% [16]. - The DPR is 35.79%, allowing potential for future dividend increases [16]. - WMK shares have shown bullish signals, with a breakout above the 50-day SMA and an RSI indicating upward momentum [18]. - **Calavo Growers Inc. (CVGW)**: - Benzinga Edge Value Score of 80.91, with a dividend yield of 3.09% and a DPR of 72% [19]. - The company operates in the fresh produce sector, which is less affected by tariffs [19]. - CVGW shares have surged nearly 20% recently, breaking above key moving averages [21].

Financial Data and Key Metrics Changes - The company has transitioned to a focus on IoT-connected beauty devices, with a significant emphasis on the wellness market, which is projected to reach a trillion dollars by 2030 [2][19] - The company has established itself as the world's largest beauty and wellness device systems brand, indicating strong market positioning [2] Business Line Data and Key Metrics Changes - The introduction of Prysm iO is aimed at enhancing customer experience through personalized solutions based on biomarker data, which is expected to drive recurring revenue streams [6][12] - The company has developed a proprietary AI-informed algorithm to provide nutritional health scores, leveraging a large database of over 26 million scans from more than 10 million individuals [8][12] Market Data and Key Metrics Changes - The company is expanding into India, a market with 1.6 billion people, which is seen as a significant growth opportunity, especially with a digital-first approach [19][20] - The company has learned from its experiences in Latin America, which has become its fastest-growing segment, and plans to apply these lessons in India [18][21] Company Strategy and Development Direction - The company aims to diversify its market presence to avoid over-reliance on any single region, particularly after losing business in China due to geopolitical tensions [25][26] - The strategy includes leveraging local partnerships and digital-first approaches to penetrate emerging markets effectively [20][21] Management's Comments on Operating Environment and Future Outlook - Management believes that the market undervalues the company due to its direct sales channel, despite having strong technology and product solutions [31][32] - The company anticipates that the rollout of Prysm iO will significantly enhance its revenue potential and stabilize the business as it returns to growth in the coming years [36][38] Other Important Information - The company has a unique model that combines product solutions with data insights, which differentiates it from competitors in the wellness and beauty sectors [12][32] - The company is focused on ensuring that its nutritional supplements are effective and absorbed by the body, addressing a significant market need [14] Q&A Session Summary Question: How does the company plan to roll out and adopt Prysm iO? - The company plans to focus on training its sales force in the first half of the year, followed by a consumer launch in the second half, expecting significant growth in household-based subscriptions [37] Question: What lessons from Latin America will inform the strategy in India? - The company has learned about pricing, positioning, and consumer education from its Latin America experience, which will be applied to the Indian market [18][21] Question: How is the company navigating regional volatility? - The company has diversified its business across multiple regions to reduce risk and is now evenly distributed across its segments, which is seen as beneficial for shareholders [25][26]